Colombo Carla

Fixed-term Research Fellow B
SSD
MED/13 - ENDOCRINOLOGY AND METABOLISM
Competition sector
06/D2 - ENDOCRINOLOGY, NEPHROLOGY, FOOD AND WELLNESS SCIENCE

Contacts

Workplace

Via Della Commenda, 9 - Ospedale Maggiore Policlinico - Pad. De Marchi
20122 MILANO (MI)

University email address
Research

Publications

Publications
  • The molecular and gene/miRNA expression profiles of radioiodine resistant papillary thyroid cancer / C. Colombo, E. Minna, C. Gargiuli, M. Muzza, M. Dugo, L. De Cecco, G. Pogliaghi, D. Tosi, G. Bulfamante, A. Greco, L. Fugazzola, M. Borrello. - In: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. - ISSN 1756-9966. - 39:1(2020 Nov 16).
  • High Prevalence and Conservative Management of Acute Cholecystitis during Lenvatinib for Advanced Thyroid Cancer / M. Di Stefano, C. Colombo, S. De Leo, M. Perrino, M. Viganò, L. Persani, L. Fugazzola. - In: EUROPEAN THYROID JOURNAL. - ISSN 2235-0640. - (2020 Sep 16), pp. 1-9. [Epub ahead of print]
  • Lenvatinib as first-line treatment for advanced thyroid cancer: long progression-free survival / S. De Leo, M. Di Stefano, L. Persani, L. Fugazzola, C. Colombo. - In: ENDOCRINE. - ISSN 1355-008X. - (2020 Sep 03). [Epub ahead of print]
  • Body Composition and Leptin/Ghrelin Levels during Lenvatinib for Thyroid Cancer / S. De Leo, C. Colombo, M. Di Stefano, A. Dubini, S. Cozzi, L. Persani, L. Fugazzola. - In: EUROPEAN THYROID JOURNAL. - ISSN 2235-0640. - 9:1(2020 Jan 01), pp. 1-10.
  • BRAF V600E status may facilitate decision-making on active surveillance of low-risk papillary thyroid microcarcinoma / K. Kim, S. Kim, J. Tan, X. Shen, D. Viola, R. Elisei, E. Puxeddu, L. Fugazzola, C. Colombo, B. Jarzab, A. Czarniecka, A. Lam, C. Mian, F. Vianello, L. Yip, G. Riesco-Eizaguirre, P. Santisteban, C. O'Neill, M. Sywak, R. Clifton-Bligh, B. Bendlova, V. Sýkorová, M. Xing. - In: EUROPEAN JOURNAL OF CANCER. - ISSN 0959-8049. - 124(2020 Jan), pp. 161-169.